Qing-ya Cui Hong-shi Shen Tian-qin Wu Hai-fei Chen Zi-qiang Yu Zhao-yue Wang
10.2147/DDDT.S68682
Drug Des Devel Ther
2015 Apr 24;9:2395-8.
acquired factor v deficiency coagulopathy prednisone
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/25987837/
Anti-Bacterial Agents / adverse effects Ceftazidime / adverse effects Factor V / antagonists & inhibitors Factor V Deficiency / chemically induced Factor V Deficiency / drug therapy
Anti-Bacterial Agents / adverse effects Ceftazidime / adverse effects Factor V / antagonists & inhibitors Factor V Deficiency / chemically induced Factor V Deficiency / drug therapy Case Reports Research Support, Non-U.S. Gov't Anti-Bacterial Agents / therapeutic use Anti-Inflammatory Agents / therapeutic use Blood Coagulation Tests Brain Stem / diagnostic imaging Brain Stem / pathology Ceftazidime / therapeutic use Humans Intracranial Hemorrhages / complications Intracranial Hemorrhages / diagnostic imaging Intracranial Hemorrhages / pathology Male Middle Aged Plasma Prednisone / therapeutic use Prothrombin / therapeutic use Tomography, X-Ray Computed Anti-Bacterial Agents Anti-Inflammatory Agents Factor V Prothrombin Ceftazidime Prednisone
PMC4422287
25987837
Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature
2015